Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Ira Turner

Neurology Plainview, NY Medical Doctor

NPI 1306822929 CMS profile 58669

824 Old Country Rd, Plainview, NY 11803

Open in the dashboard

General payments

$596,812

972 records reported · program years 2019–2023

Research payments

$9,880

Paid to them · 5 records reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$58,437 paid to institutions, not to them · program years 2019–2022

Through program year 2023, Ira Turner of Plainview, NY is reported in the CMS Open Payments database as having received $596,812 across 972 general payments and $9,880 in research payments paid to them. Separately, studies naming them as principal investigator received $58,437 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $183 3
2023 Research $940 1
2022 General $79,279 124
2021 General $208,880 312
2021 Research $4,878 1
2020 General $131,097 228
2020 Research $3,808 2
2019 General $177,374 305
2019 Research $255 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ira Turner
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Ira Turner were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Ira Turner Neurology median Middle half National median
2019 $177,374 $474 $118–$2,177 $163
2020 $131,097 $367 $82–$2,309 $114
2021 $208,880 $438 $104–$2,547 $132
2022 $79,279 $442 $103–$2,388 $149
2023 $183 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Allergan Inc. $148,194 230 payments
  2. Lilly USA, LLC $86,805 171 payments
  3. Amgen Inc. $85,769 105 payments
  4. AbbVie, Inc. $84,785 157 payments
  5. Teva Pharmaceuticals USA, Inc. $67,658 91 payments
  6. Lundbeck LLC $39,699 52 payments
  7. Biohaven Pharmaceuticals, Inc. $29,309 42 payments
  8. Impel Pharmaceuticals Inc. $26,257 15 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $13,716 22 payments
  10. Promius Pharma LLC $4,958 7 payments
  11. Other $9,661 80 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $429,184 238 payments
  2. Consulting Fee $77,738 32 payments
  3. Travel and Lodging $37,223 137 payments
  4. Honoraria $27,163 13 payments
  5. Food and Beverage $22,681 546 payments
  6. Grant $2,588 3 payments
  7. Education $236 3 payments
Products named General payments · program years 2019–2023
  1. AIMOVIG $82,331 109 payments
  2. BOTOX $76,118 64 payments
  3. UBRELVY Neuroscience $74,622 119 payments
  4. UBRELVY Neuroscience $47,283 85 payments
  5. EMGALITY $45,688 83 payments
  6. NURTEC ODT $43,025 64 payments
  7. VYEPTI $39,552 50 payments
  8. AJOVY Central Nervous System $39,511 54 payments
  9. Ajovy Central Nervous System $27,960 32 payments
  10. Trudhesa $26,257 15 payments
  11. Other $64,051 228 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2023
  1. Eli Lilly and Company $4,936 2 payments
  2. Novartis Pharmaceuticals Corporation $4,005 2 payments
  3. Pfizer Inc. $940 1 payment

Records

977 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record